| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Breno Toledo Pires de Oliveira CEO | B3 Exchange | BRHYPEACNOR0 ISIN |
| BR Country | 10,481 Employees | 29 Sep 2025 Last Dividend | 4 Jan 2010 Last Split | - IPO Date |
Hypera S.A. is a prominent pharmaceutical company based in Brazil, known for its expansive portfolio of healthcare products. Initially established in 2001 under the name Hypermarcas S.A., the company underwent a name change to Hypera S.A. in February 2018, signifying a new era in its history. Operating primarily within Brazil, Hypera S.A. specializes in developing, producing, and marketing a wide range of pharmaceutical products, including prescription medications, over-the-counter (OTC) drugs, and nutritional supplements. Its mission centers on delivering high-quality healthcare solutions to improve the well-being of its consumer base. Headquartered in São Paulo, Brazil, Hypera S.A. stands as a leading entity in the Latin American pharmaceutical landscape.
Hypera S.A. offers an extensive variety of products and services categorized into several segments: pharmaceuticals, consumer health products, and nutritional and vitamin supplements. Listed below are some of the company's notable products and brands: